Beam Therapeutics Inc (BEAM)
21.47
-0.13
(-0.60%)
USD |
NASDAQ |
Apr 26, 09:30
Beam Therapeutics Total Return Level: 21.60 for April 25, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 25, 2024 | 21.60 |
April 24, 2024 | 22.74 |
April 23, 2024 | 23.47 |
April 22, 2024 | 24.10 |
April 19, 2024 | 23.90 |
April 18, 2024 | 24.31 |
April 17, 2024 | 24.31 |
April 16, 2024 | 25.70 |
April 15, 2024 | 25.70 |
April 12, 2024 | 25.93 |
April 11, 2024 | 27.27 |
April 10, 2024 | 27.06 |
April 09, 2024 | 29.32 |
April 08, 2024 | 28.81 |
April 05, 2024 | 28.20 |
April 04, 2024 | 29.03 |
April 03, 2024 | 29.68 |
April 02, 2024 | 30.55 |
April 01, 2024 | 32.66 |
March 28, 2024 | 33.04 |
March 27, 2024 | 33.96 |
March 26, 2024 | 33.22 |
March 25, 2024 | 33.69 |
March 22, 2024 | 33.63 |
March 21, 2024 | 34.95 |
Date | Value |
---|---|
March 20, 2024 | 34.87 |
March 19, 2024 | 34.84 |
March 18, 2024 | 34.06 |
March 15, 2024 | 35.41 |
March 14, 2024 | 34.61 |
March 13, 2024 | 37.37 |
March 12, 2024 | 35.80 |
March 11, 2024 | 36.57 |
March 08, 2024 | 37.53 |
March 07, 2024 | 36.96 |
March 06, 2024 | 38.28 |
March 05, 2024 | 38.51 |
March 04, 2024 | 38.24 |
March 01, 2024 | 39.84 |
February 29, 2024 | 39.49 |
February 28, 2024 | 43.61 |
February 27, 2024 | 45.07 |
February 26, 2024 | 35.80 |
February 23, 2024 | 33.99 |
February 22, 2024 | 33.54 |
February 21, 2024 | 31.76 |
February 20, 2024 | 31.80 |
February 16, 2024 | 32.90 |
February 15, 2024 | 33.02 |
February 14, 2024 | 31.29 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
13.31
Minimum
Mar 16 2020
133.60
Maximum
Jul 01 2021
49.69
Average
39.12
Median
Total Return Level Benchmarks
Eli Lilly and Co | 2086.49 |
Moderna Inc | 106.18 |
Pfizer Inc | 86.33 |
Editas Medicine Inc | 5.22 |
Intellia Therapeutics Inc | 20.02 |